Pandemic Disruptions and Delayed Care Worsened Stroke Outcomes Globally
Stroke care experienced profound disruptions during the COVID-19 pandemic, characterized by a sharp drop in hospital admissions, significant treatment delays, and poorer patient recovery outcomes. A scoping review published in BMC Health Services Research by Ménard and colleagues analysed 107 studies published between December 2019 and September 2024, revealing that widespread changes in healthcare utilization and patient behavior heavily compromised the stroke care continuum.
Additional systematic reviews corroborate these findings on a global scale. Research published in BMJ Open by RAVD and KA noted that 84% of examined studies reported decreased hospital admission rates for stroke during the pandemic, alongside an increase in patient mortality and treatment times. As healthcare facilities faced immense strain, workforce shortages, and the implementation of strict COVID-19 protocols, the overall quality and speed of emergency neurological care declined.
Patient Behavioral Shifts and Treatment Delays
Patients frequently delayed seeking medical attention during the pandemic due to fears of contracting COVID-19 in hospital environments and the perception that healthcare services were overwhelmed. This reluctance was particularly pronounced among individuals experiencing milder stroke symptoms. Consequently, many patients arrived outside critical therapeutic windows, which limited the effectiveness of acute interventions.
While the rapid adoption of telemedicine helped maintain some continuity of care for younger populations, lower utilization rates among older adults exposed persistent inequalities in remote healthcare access. Data showed that reduced emergency department visits for less severe cases directly correlated with a higher proportion of severe presentations upon arrival.
Hospital Admissions and Escalated Disease Severity
Reductions in monthly stroke admissions ranged significantly across different regions and healthcare systems. Studies cited within the scoping review documented drops in ischemic stroke admissions ranging from 31% to 44%. Patients who did reach the hospital often presented with more advanced disease states, driven by a combination of delayed presentation, social isolation, and avoidance of emergency services.
This delayed intervention translated into worse functional outcomes and elevated mortality rates. The scoping review highlighted that disability at discharge was significantly higher during the pandemic, with patients recording a median modified Rankin Scale score of 4, compared to a pre-pandemic score of 2. These functional deficits persisted at three months post-stroke. Furthermore, in-hospital mortality at discharge rose sharply, with studies reporting rates of 7.7% during the pandemic compared to 2.5% in pre-pandemic cohorts.
Healthcare System Strain and Protocol Impacts
Healthcare infrastructure buckling under pandemic pressures forced rapid resource reallocation and altered established stroke care pathways. According to the systematic review in BMJ Open, infection control protocols and overstretched resources resulted in increased treatment times in 60% of evaluated studies. In-hospital mortality increased across 82% of the studies reviewed, showing an average doubling of mortality rates during the crisis.
Despite these systemic bottlenecks, the primary prevalence of stroke subtypes—such as ischemic versus hemorrhagic strokes—and frontline revascularization methods like mechanical thrombectomy and thrombolysis remained consistent. The primary driver of poorer outcomes was not a shift in stroke pathobiology, but rather the operational delays and hesitancy in acute care delivery.
Future Pandemic Preparedness and Emergency Response
Researchers emphasize that public health emergency planning must adapt to protect vulnerable neurological patients during widespread health crises. Future preparedness frameworks must prioritize adaptable stroke care pathways, equitable access to telemedicine platforms, targeted public education campaigns to prevent care-seeking delays, and resilient hospital workflows that safeguard emergency medical services from complete paralysis.
Frequently Asked Questions
What caused the reduction in stroke admissions during the COVID-19 pandemic?
Patients frequently delayed seeking emergency care because of concerns about contracting COVID-19 inside hospitals and the belief that healthcare facilities were overburdened. This behavior was especially common among individuals with milder stroke symptoms.
How did treatment times and mortality rates change during the pandemic?
In-hospital stroke treatment pathways were disrupted by COVID-19 protocols, resulting in increased treatment times in 60% of studies. Additionally, in-hospital mortality rates at discharge rose to 7.7% during the pandemic compared to 2.5% in pre-pandemic cohorts.
Did the types of strokes or primary treatments change during this period?
The prevalence of specific stroke subtypes, such as ischemic or hemorrhagic strokes, and primary treatment methods like mechanical thrombectomy and thrombolysis did not vary significantly due to the pandemic.
Keep reading